|
DK1067910T3
(da)
|
1998-04-03 |
2004-10-04 |
Egalet As |
Komposition med styret afgivelse
|
|
US20040253310A1
(en)
|
2001-09-21 |
2004-12-16 |
Gina Fischer |
Morphine polymer release system
|
|
US20050019399A1
(en)
*
|
2001-09-21 |
2005-01-27 |
Gina Fischer |
Controlled release solid dispersions
|
|
WO2003024429A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Polymer release system
|
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
JP2006500320A
(ja)
*
|
2002-04-30 |
2006-01-05 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
カルベジロール一クエン酸塩一水和物
|
|
CA2492084A1
(en)
|
2002-06-27 |
2004-01-08 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol hydobromide
|
|
BR0312102A
(pt)
|
2002-06-27 |
2007-05-29 |
Sb Pharmco Inc |
sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento
|
|
WO2004041252A1
(en)
*
|
2002-11-08 |
2004-05-21 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
WO2004047837A2
(en)
*
|
2002-11-22 |
2004-06-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-blockers having antioxidant and nitric oxide-donor activity
|
|
US8877241B2
(en)
|
2003-03-26 |
2014-11-04 |
Egalet Ltd. |
Morphine controlled release system
|
|
DE602004014747D1
(de)
*
|
2003-03-26 |
2008-08-14 |
Egalet As |
Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen
|
|
ES2335008T3
(es)
*
|
2003-04-24 |
2010-03-18 |
Jagotec Ag |
Comprimido con nucleo coloreado.
|
|
US7260685B2
(en)
|
2003-06-20 |
2007-08-21 |
Micron Technology, Inc. |
Memory hub and access method having internal prefetch buffers
|
|
AR045637A1
(es)
*
|
2003-09-12 |
2005-11-02 |
Amgen Inc |
Formulacion de disolucion rapida de un compuesto activo frente a los receptores de calcio
|
|
US7120743B2
(en)
|
2003-10-20 |
2006-10-10 |
Micron Technology, Inc. |
Arbitration system and method for memory responses in a hub-based memory system
|
|
EP1686967A4
(en)
*
|
2003-11-25 |
2012-08-08 |
Smithkline Beecham Cork Ltd |
CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
|
|
JP2007512372A
(ja)
|
2003-11-25 |
2007-05-17 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
カルベジロール塩、対応する組成物、送達および／または治療方法
|
|
JP5072364B2
(ja)
*
|
2003-11-25 |
2012-11-14 |
スミスクライン ビーチャム （コーク） リミテッド |
カルベジロール遊離塩基、カルベジロール塩、無水形態またはその溶媒和物、対応する医薬組成物、制御放出処方および治療またはデリバリー方法
|
|
WO2005079752A2
(en)
*
|
2004-02-11 |
2005-09-01 |
Rubicon Research Private Limited |
Controlled release pharmaceutical compositions with improved bioavailability
|
|
NZ563846A
(en)
*
|
2005-06-03 |
2010-03-26 |
Egalet As |
A drug delivery system for delivering active substances dispersed in a dispersion medium
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
WO2007144785A2
(en)
*
|
2006-03-26 |
2007-12-21 |
Uti Limited Partnership |
Ryanodine receptor inhibitors and methods relating thereto
|
|
PT2049123E
(pt)
|
2006-08-03 |
2013-03-06 |
Horizon Pharma Ag |
Tratamento de doença reumatóide com glucocorticóide de libertação retardada
|
|
WO2008070072A2
(en)
*
|
2006-12-01 |
2008-06-12 |
Mutual Pharmaceutical Company, Inc. |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
US20090028935A1
(en)
*
|
2006-12-01 |
2009-01-29 |
Kristin Arnold |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
EP2104493A2
(en)
*
|
2007-01-16 |
2009-09-30 |
Egalet A/S |
Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
WO2008114276A1
(en)
*
|
2007-03-16 |
2008-09-25 |
Lupin Limited |
Novel oral controlled release composition of carvedilol
|
|
BRPI0701904A2
(pt)
*
|
2007-04-27 |
2008-12-09 |
Libbs Farmaceutica Ltda |
forma farmacÊutica de liberaÇço controlada de princÍpios ativos com solubilidade dependente do baixo ph do meio e processo para preparar a forma farmacÊutica
|
|
US8821928B2
(en)
|
2007-06-04 |
2014-09-02 |
Egalet Ltd. |
Controlled release pharmaceutical compositions for prolonged effect
|
|
EP2391369A1
(en)
*
|
2009-01-26 |
2011-12-07 |
Nitec Pharma AG |
Delayed-release glucocorticoid treatment of asthma
|
|
NZ594207A
(en)
|
2009-02-06 |
2013-03-28 |
Egalet Ltd |
Immediate release composition resistant to abuse by intake of alcohol
|
|
AU2010265213B2
(en)
|
2009-06-24 |
2012-08-23 |
Egalet Ltd. |
Controlled release formulations
|
|
TWI415604B
(zh)
*
|
2009-09-29 |
2013-11-21 |
Tsh Biopharm Corp Ltd |
調控釋放卡菲蒂羅劑型
|
|
JP5714562B2
(ja)
*
|
2010-02-22 |
2015-05-07 |
第一三共株式会社 |
経口用徐放性固形製剤
|
|
EP2540318B1
(en)
|
2010-02-22 |
2018-10-24 |
Daiichi Sankyo Company, Limited |
Sustained-release solid preparation for oral use
|
|
JP2015521988A
(ja)
|
2012-07-06 |
2015-08-03 |
イガレット・リミテッド |
制御放出用乱用防止性医薬組成物
|
|
RU2665372C2
(ru)
|
2012-09-03 |
2018-08-29 |
Дайити Санкио Компани, Лимитед |
Пероральная фармацевтическая композиция замедленного высвобождения, содержащая гидрохлорид гидроморфона
|
|
KR102241487B1
(ko)
|
2013-02-20 |
2021-04-16 |
주식회사 종근당 |
제어방출 펠릿으로 된 약제학적 조성물
|
|
KR102158339B1
(ko)
|
2016-02-05 |
2020-09-21 |
삼진제약주식회사 |
인습성이 개선된 카르베딜롤 속방성 제제
|